47 related articles for article (PubMed ID: 27136623)
1. Eye and lid involvement as an uncommon feature of pemphigus foliaceus in a pediatric patient.
Garza-Dávila VF; Santana-Gutiérrez A; Zapata-Salazar N; Vázquez-Martínez O; Ocampo-Candiani J; Fernández-de Luna ML; Mohamed-Noriega K; Alba-Rojas E
Pediatr Dermatol; 2024 Mar; ():. PubMed ID: 38459607
[TBL] [Abstract][Full Text] [Related]
2. Feline pemphigus foliaceus: original case series and a comprehensive literature review.
Bizikova P; Burrows A
BMC Vet Res; 2019 Jan; 15(1):22. PubMed ID: 30626385
[TBL] [Abstract][Full Text] [Related]
3. Eosinophilc polymorphic pruritic eruption associated with radiotherapy (EPPER syndrome) in a patient with breast cancer.
Colmenero M; Gutiérrez P; Blázquez N
Med Clin (Barc); 2021 Sep; 157(5):260-261. PubMed ID: 32843220
[No Abstract] [Full Text] [Related]
4. COVID-19-associated pemphigus foliaceus exacerbated by toll-like receptor 7 agonist.
Oya K; Ishii Y; Takeyama S; Homma Y; Nomura T
J Dermatol; 2024 Apr; ():. PubMed ID: 38629722
[No Abstract] [Full Text] [Related]
5. Single fiber EMG as a prognostic tool in myasthenia gravis.
Baruca M; Leonardis L; Podnar S; Hojs-Fabjan T; Grad A; Jerin A; Blagus R; Šega-Jazbec S
Muscle Nerve; 2016 Dec; 54(6):1034-1040. PubMed ID: 27144873
[TBL] [Abstract][Full Text] [Related]
6. Idiopathic Pulmonary Fibrosis and Myasthenia Gravis: An Unusual Association.
Chogtu B; Malik DV; Magazine R
J Clin Diagn Res; 2016 Apr; 10(4):OD06-7. PubMed ID: 27190866
[TBL] [Abstract][Full Text] [Related]
7. Muscle-Specific Receptor Tyrosine Kinase (MuSK) Myasthenia Gravis.
Hurst RL; Gooch CL
Curr Neurol Neurosci Rep; 2016 Jul; 16(7):61. PubMed ID: 27170368
[TBL] [Abstract][Full Text] [Related]
8. MG-QoL-15 scores in treated myasthenia gravis: Experience from a university hospital in India.
Kumar R; Nagappa M; Sinha S; Taly AB; Rao S
Neurol India; 2016; 64(3):405-10. PubMed ID: 27147146
[TBL] [Abstract][Full Text] [Related]
9. International clinimetric evaluation of the MG-QOL15, resulting in slight revision and subsequent validation of the MG-QOL15r.
Burns TM; Sadjadi R; Utsugisawa K; Gwathmey KG; Joshi A; Jones S; Bril V; Barnett C; Guptill JT; Sanders DB; Hobson-Webb L; Juel VC; Massey J; Gable KL; Silvestri NJ; Wolfe G; Cutter G; Nagane Y; Murai H; Masuda M; Farrugia ME; Carmichael C; Birnbaum S; Hogrel JY; Nafissi S; Fatehi F; Ou C; Liu W; Conaway M
Muscle Nerve; 2016 Dec; 54(6):1015-1022. PubMed ID: 27220659
[TBL] [Abstract][Full Text] [Related]
10. Ptosis Repair in Ocular Myasthenia Gravis.
Belliveau MJ; Oestreicher JH
Semin Ophthalmol; 2017; 32(5):564-568. PubMed ID: 27191622
[TBL] [Abstract][Full Text] [Related]
11. The mechanism of acetylcholine receptor in binding MuSK in myasthenia gravis and the role of HSP90 molecular chaperone.
Chen R; Chen S; Liao J; Chen X; Xu X
Am J Transl Res; 2016; 8(4):1763-8. PubMed ID: 27186300
[TBL] [Abstract][Full Text] [Related]
12. GR gene polymorphism is associated with inter-subject variability in response to glucocorticoids in patients with myasthenia gravis.
Xie Y; Meng Y; Li HF; Hong Y; Sun L; Zhu X; Yue YX; Gao X; Wang S; Li Y; Kusner LL; Kaminski HJ
Eur J Neurol; 2016 Aug; 23(8):1372-9. PubMed ID: 27185333
[TBL] [Abstract][Full Text] [Related]
13. Genetic heterogeneity within the HLA region in three distinct clinical subgroups of myasthenia gravis.
Saruhan-Direskeneli G; Hughes T; Yilmaz V; Durmus H; Adler A; Alahgholi-Hajibehzad M; Aysal F; Yentür SP; Akalin MA; Dogan O; Marx A; Gülsen-Parman Y; Oflazer P; Deymeer F; Sawalha AH
Clin Immunol; 2016 May; 166-167():81-8. PubMed ID: 27181991
[TBL] [Abstract][Full Text] [Related]
14. Curcumin ameliorates experimental autoimmune myasthenia gravis by diverse immune cells.
Wang S; Li H; Zhang M; Yue LT; Wang CC; Zhang P; Liu Y; Duan RS
Neurosci Lett; 2016 Jul; 626():25-34. PubMed ID: 27181511
[TBL] [Abstract][Full Text] [Related]
15. Anti-MuSK myasthenia gravis with prolonged remission.
Bouwyn JP; Magnier P; Bédat-Millet AL; Ahtoy P; Maltête D; Lefaucheur R
Neuromuscul Disord; 2016 Jul; 26(7):453-4. PubMed ID: 27161384
[TBL] [Abstract][Full Text] [Related]
16. Marked to Die-Cell Death Mechanisms for Keratinocyte Acantholysis in Pemphigus Diseases.
Bumiller-Bini Hoch V; Schneider L; Pumpe AE; Lüders E; Hundt JE; Boldt ABW
Life (Basel); 2022 Feb; 12(3):. PubMed ID: 35330080
[TBL] [Abstract][Full Text] [Related]
17. Radiation-Associated Pemphigus Vulgaris in a Patient With Preceding Malignancy: Treatment With Rituximab as a Valuable Option.
Schauer F; Ishii N; Mockenhaupt M; Bruckner-Tuderman L; Hashimoto T; Kiritsi D
Front Immunol; 2019; 10():3116. PubMed ID: 32038636
[TBL] [Abstract][Full Text] [Related]
18. Pemphigus foliaceus exacerbated by radiation, in association with myasthenia gravis.
Liebman TN; Lieberman MR; Burris K
Dermatol Online J; 2016 Mar; 22(3):. PubMed ID: 27136623
[TBL] [Abstract][Full Text] [Related]
19. Coexistence of myasthenia gravis and pemphigus foliaceus.
Kim HT; Kim SH; Kim JH; Kim MH; Lee CW
J Korean Med Sci; 1995 Aug; 10(4):298-302. PubMed ID: 8593212
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
